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Abstract
Located in the extracellular matrix (ECM) of the cartilaginous tissues such as human intervertebral disc,
the large self-assembling proteoglycans, aggrecan, are essential for the disc in resisting multiaxial
compressive loads. Aggrecan degradation, a combinational result of abnormal and/or reduced cellular
synthesis and proteolytic cleavage, leads to a reduction in the disc functionality. The knowledge of how
aggrecan distributes at different stage of degradation on a molecular level can help reveal both the
processes of aggrecan degradation and that of human intervertebral disc degeneration and repair. This
thesis will cover both the experimental work and the simulation work in an attempt to fully understand
aggrecan structure and the origin of its mechanical properties.
The experimental study utilizes high resolution atomic force microscopy (AFM) to directly
visualize the single molecular conformation of aggrecan before and after removal of keratan sulfate (KS)
or chondroitin sulfate (CS) glycosaminoglycans (GAGs) via enzymes Keratanase II (K'ase) and
Chondroitinase ABC (C'ase) respectively. The aggrecan was extracted and purified from the
intervertebral disc of a 24-year old human (obtained from the Shriner's Hospital, Montreal) and
separated into two pools: the HA-associated pool is composed of aggrecan proteoglycans that were
originally attached to hyaluronic acid (HA) in vivo; while the non-HA-associated pool constitutes the
aggrecan that lack in G1 domains and were floating around the ECM. The aggrecan solutions were
deposited on 3-aminopropyltriethoxysilane functionalized mica substrates and imaged via tapping mode
AFM (tip radius <10 nm) after air dried. The results have shown that aggrecan from normal human disc
(24 yr) appears highly degraded, composed mainly of short fragments, and that the non-HA associated
molecules are composed primarily of the degradation products and arise because of entrapment in the
unique matrix organization of the disc. We can infer that the trace length of aggrecan core protein is
extended by GAG chains, specifically by CS GAGs, and this hypothesis leads to study GAG specifically by
Molecular Dynamic (MD) Simulations.
It has been found that the sulfation type (4- versus 6-sulfation) and sulfation pattern vary with
age in articular cartilage and intervertebral disc. This MD simulation study developed an implicit
solvation model of three types of tetrasaccharides of both sulfated and unsulfated chondroitin, namely,
chondroitin 4-sulfate (C4S), chondroitin 6-sulfate (C6S) and chondroitin (CN). In this model, water is
treated implicitly as a continuum medium by incorporating its electrostatic screening and viscous
effects. The structural analysis on the atomic level based on the temporal dynamics of these
tetrasaccharides suggested a closer similarity between 4 and 6-sulfated chondroitin as compared to
between sulfated and unsulfated chondroitin. To note, this implicit solvation model provides a
consistent result with explicit solvation models of GAGs, indicated by the maintenance of 3-fold helix
structure. We have also observed the intramolecular hydrogen bonds that are present intermittently on
the sub-nanosecond time scale and cooperate with the glycosidic torsion angles. In future, a coarse-
grained model based on this all-atom simulation will provide us with a better understanding of the
dynamic properties of aggrecan proteoglycans.
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Chapter 1
Introduction
1.1 Structure of aggrecan proteoglycans and glycosaminoglycans
Proteoglycans are glycosaminoglycan (GAG)-containing molecules, and exist extensively in mammalian
tissues along with collage fibers.[1] Aggrecan is the most abundant and important proteoglycan located
in the extracellular matrix (ECM) of cartilaginous tissues such as articular cartilage [2] and intervertebral
disc (IVD) [3] in human beings along with other mammalian animals (Figure 1-lError! Reference source
not found.). A "full-length" aggrecan (prior to enzymatic degradation) monomer is cylindrical "bottle
brush"-like molecule, consisting of a protein backbone of 220-250 kDa with three globular domains,
namely, G1, G2 and G3 domains (Figure 1-2). [4] The G1 domain comprises the amino terminus of the
core protein, while G3 carboxyl terminus. The "brushes" are negatively charged chains of
glycosaminoglycan covalently attached to the serine sites along the protein core between G2 and G3
domains. [5]
Under the physiological conditions, aggrecan can form large aggregates by self-assembly. [6]
Hyaluronic acid (HA) acts as a scaffold in aggrecan self-assembling process by binding non-covalently to
the G1 domain of aggrecan molecules stabilized by the link protein (LP).[7] The aggrecan/HA aggregates
are enmeshed in a network of collagen fibers. This secondary "bottle brush"-like architecture of
aggregated aggrecan molecules along the central filament HA is thought to prevent aggrecan monomers
from diffusing out of the ECM.
Glycosaminoglycans are unbranched polysaccharides consisting of repeating disaccharide
units.[1] The class of glycosaminoglycans includes chondroitin 4-sulfate, chondroitin 6-sulfate, keratan
sulfate, hyaluronic acid, heparan sulfate and dermatan sulfate etc.[8] Due to the large number of the
carboxyl groups and sulfate groups or both, glycosaminoglycans are by nature polyanions. The high
negativity in charge of GAG chains is essential to the biochemical and biomechanical properties of the
mammalian extracellular matrix, and renders the molecular origin of osmotic pressure inside the tissue.
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Along the protein core of aggrecan molecules, the long linear region between the G2 and C-
terminal G3 domains is the principal region of the molecule substituted with GAG chains. Chondroitin
sulfate (CS, 100 - 150 per aggrecan monomer) is a major component found in aggrecan molecules, and it
locates primarily near the C terminus of the aggrecan protein core. Aggrecan chondroitin sulfate has
two sulfation types: chondroitin 4-sulfate (C4S) and chondroitin 6-sulfate (C6S), and it has been found
that the sulfation type (4- versus 6-sulfation) and sulfation pattern vary with age and disease in human
articular cartilage.[9] In contrary to chondroitin sulfate, keratan sulfate (KS, 30 - 60 per aggrecan
monomer) is preferentially located towards the N terminus. [6]
Figure 1-1: The molecular organization of normal articular cartilage. (Cited from Heinegerd 2010 [10])
T-f1 LGaINMc-4/6-sulfate GUA
5 (1-3- linkage$ (19 ) likage 0 (144) linkage
Hyaluronan CS-1 CS-2
Link protein KS(hmn
2396 a.a.
350 kDa
1 2 34 5 61 1 1
(A) (B) (C) (D) (E)
4- G1-VDIPEN-"
4 - GI-NITEGE 373
Figure 1-2: (a) The molecular structure of aggrecan proteoglycans and the chemistry of the side chains,
glycosaminoglycans. (b) Aggrecan cleavage sites by aggrecanases and matrix metalloproteinases (MMPs). (cited
from reference [11])
It has been shown that aggrecan proteoglycans undergo proteolytic cleavage at a number of
different sites [12], among which the two most extensively characterized cleavage sites are located
within the interglobular domain, the extended region between the G1 and G2 domain, and are targeted
by metalloproteinases (MMPs) and aggrecanases, as shown in Figure 1-2(b). The degradation processes
of aggrecan proteoglycans are thought to be modulated by the mechanical loads. The G1-containing
degradation products of aggrecan by metalloproteinases and aggrecanases can still be detained inside
the tissue by binding to HA. Despite the importance of both metalloproteinases and aggrecanase in the
degradation of aggrecan in human intervertebral disc and articular cartilage in vivo [12], other agents
may contribute as well. With age and disease, the functional properties of tissues are altered or
reduced, and the molecular origin of these aging effects is decreased aggrecan synthesis, aggrecan
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Sites cleaved by aggrecanases
(A) ... RNITEGE373 374 ARGSVIL...
(A) (G) (1480) (1481) (D)(B) ...STASELE' 5  ' 6GRGTIGI...
11667) (1668)
(C) .. TTFKEEE'714  '71'5GLGSVEL...
(1771)1772)
(D) ...QAPTAQE 8s 9 i'8 AGEGPSG...
(V) (1871) 1872)
(E) ...EPTISQE'9 19 192 0LGQRPPV...
Sites cleaved by MMPs
(S)
1 ... FVDIPEN-4 -142 FFGVGGE...
2 ... TAFTSED4' 42 LVVQVTA...
(V) (A)
3 ... HAFCFRGw6 667 ISAVPSP...
4 not determined
5 not determined
6 not determined
depletion from the tissue through diffusion and proteolytic degradation and the accumulation of
degradation products that might compete with newly synthesized aggrecan molecules.
1.2 Aggrecan's role in human intervertebral disc degeneration
The role of aggrecan in human articular cartilage has been extensively reported and reviewed [13], and
relatively little is known about the aggrecan degradation process in human intervertebral disc. This
section will focus on discussing the structure and function of the human intervertebral disc, age or
disease related disc degeneration process and the role of aggrecan degradation in disc degeneration.
The intervertebral disc is the fibrocartilaginous tissue consisting of a hydrated central nucleus
pulposus (NP) surrounded by the lamellar annulus fibrosus (AF), as shown in Figure 1-3. A healthy disc
provides axial compression, flexion and extension under mechanical loadings.[14]
Spinal diseases, such as spine stiffness, low back pain and neck pain, are steadily increasing in
USA. In the year of 2004, more than 44.6 million patients visited a physician complaining an occurrence
of back pain throughout the country.[13] Despite decades of research to identify the causes of disc
degeneration, such as declining nutrition, loss of viable cells, accumulation of degraded matrix
molecules and post-translation modification of matrix proteins, a fundamental mechanistic
understanding of disc degeneration is lacking.[15]
Aggrecan helps the disc to resist compressive loads. Consistently, aggrecan has been identified
by far the most abundant proteoglycan on a weight basis among the various proteoglycans in the ECM
of the disc.[16] Aggrecan proteoglycan concentration determines the matrix water concentration, and
this effect in term provides the tissue stiffness and resilience to compression. As shown in Figure 1, for
adults, the nucleus pulposus is depicted as containing proteoglycan aggregates entrapped in a collagen
fiber work. The hydration properties of the GAG chains of aggrecan cause the tissue to swell until
equilibrium is reached, in which the swelling potential is balanced by tensile forces in the collagen
network. Compression on the spine pushes some water out of the disc which increases the aggrecan
concentration and its swelling potential in order to resist further compression. On removal of the
compressive load, disc height is restored as water is drawn back and the original equilibrium condition is
restored. The whole process indicates that any parameter that decreases proteoglycan concentration,
especially the concentration of aggrecan aggregates will reduce the function of the disc.
(b)
w/ age or
disease
Decreased
water of
nucleus
pulposus
.......... 0
Distortion
of fibers
'Iears in
lamellae
Figure 1-3: (a) Intervertebral disc is the fibro-cartilaginous tissue between vertebrae in the spinal column,
consisting of a hydrated central nucleus pulposus (NP) surrounded by the lamellar collagenous annulus fibrosus
(AF). (Cited from reference [17]) (b) A healthy disc provides axial compression, flexion and extension under
mechanical loadings. (c) The physiological changes in disc degeneration include decreased water of nucleus
pulposus, loss of disc height, distortion of fibers and tears in lamellae. (Picture cited from
http://www.coastalneurosurgery.com.au) (d)The involvement of aggrecan in intervertebral disc degeneration
and repair (cited from ref. [14])
The location and structure of aggrecan vary spatially and temporarily.[18] At birth, aggrecan is
located mainly in the outer annulus [19] and substituted with chondroitin sulfate only. With age, the
proteoglycan content of the inner annulus, the portion of keratan sulfate and the length of keratan
sulfate increase while the length of chondroitin sulfate decreases (age effect is shown in Figure 1-4). [14]
The heterogeneity of aggrecan proteoglycans [20] is further enhanced by the appearance of disease.
Human IVD degeneration is a combined effect of aging and spinal diseases.
Fetal Young Juvenile
Adolescent/ Young Adult Mature Adult/Degenerate
Figure 1-4: Variation in composition of the human nucleus pulposus with age. (Adapted from Roughly 2004 [14])
Aggrecan structural degradation, which is thought to be caused by a combination of abnormal
and/or reduced cellular synthesis and photolytic cleavage, leads to a reduction in IVD functionality.[21]
As showed in Figure 1-3(d), it was hypothesized that aggrecan proteoglycans aggregating with HA
possess short fragments, containing the highly charged chondroitin sulfate domain that possess only the
CS1 region, the shorter keratan sulfate GAGs, and the interglobular (IGD) domains containing only the
binding region G1. At the same time, free aggrecan proteoglycans that are proteolytically released from
the aggregates become trapped within the tissue; they possess degraded fragments rich in CS2 and G3
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domains, but their functionality remains unknown as they are no longer attached to the aggregates.
Based on this hypothesis, my research on the experimental part will focus on directly visualizing the
structure of human disc aggrecan using Atomic Force Microscopy to correlate its degradation with disc
degeneration.
1.4 Abbreviations
The following is an alphabetical list of abbreviations used throughout this thesis.
APTES AminoPropylTriEthoxySilane
AF Annulus Fibrosus
AFM Atomic Force Microscopy
CN Chondroitin
CS Chondroitin Sulphate
C4S Chondroitin 4-Sulphate
C6S Chondroitin 6-Sulphate
C'ase Chondroitinase ABC
ECM Extracellular Matrix
HA Hyaluronic Acid
IGD Interglobular Domain
IVD Intervertebral Disc
KS Keratan Sulphate
Keratanase II
LP Link Protein
GAG Glycosaminoglycan
MD Molecular dynamics
NP Nucleus Pulposus
VMD Visual Molecular Dynamics
SMD Steered Motion Dynamics
1.5 Thesis overview
So far, I have introduced in this chapter the background of the structure of both aggrecan molecules and
their constituent glycosaminoglycans, and discussed the important role of aggrecan degradation in disc
degeneration. In Chapter 2, I will focus on the experimental studies of human intervertebral disc
aggrecan by Atomic Force Microscopy imaging techniques to unveil its ultrastructure on the nano scale
and the variation of structural properties by enzyme digestion. In Chapter 3, I will switch the gear to the
simulation of glycosaminoglycans and discuss the simulation results which current experimental
techniques are incapable of attaining. In the final chapter, I will conclude my thesis work to date, and
provide suggestion for future direction in the molecular studies of aggrecan.
K'ase
Chapter 2
Nanomolecular Architecture of Intervertebral Disc Aggrecan
This study applies Atomic Force Microscopy (AFM) technique to individually visualize the ultrastructure
of disc aggrecan proteoglycans extracted from a 24 year-old human being. Conclusions have been
drawn by comparing the HA-associated and non-HA-associated aggrecan proteoglycans and different
enzyme treatment groups (Untreated, Keratanase treated and Chondroitinase ABC treated aggrecan).
This study established the methodology of characterizing human disc aggrecan for further investigation
of disc samples from different age groups.
2.1 Materials and methods
2.1.1 Aggrecan extraction and enzyme treatment
The specimens of aggrecan used in this study were provided by our collaborator Peter Roughley
(Shriners Hospital for Children, Montreal, QC, Canada).
The aggrecan extraction and enzyme treatment procedures are summarized in Figure 2-1. First,
aggrecan monomers were dissociatively extracted (with 4 M guanidinium chloride as described in
Appendix A) and purified from the healthy intervertebral disc of a 24-year old human (with no
separation of nucleus aggrecan and annulus aggrecan because the previous biochemical studies have
shown that there is no significant difference between the NP and AF aggrecan for young adults [22]).
Then, the extract was supplemented with hyaluronic acid, dialyzed to associative conditions, and the
proteoglycans purified by Caesium chloride (CsCI) density gradient centrifugation with Al-preparation
(density greater than 1.55 g/ml). The mixture of proteoglycan aggregates and non-aggregated
proteoglycans which were separated into two pools by gel filtration chromatography through Sepharose
CL-2B: (1) a pool composed of aggrecan or its degradation products that were attached to hyaluronic
acid via a functional G1 domain ("HA-associated") and (2) a pool consisting of aggrecan or its
degradation products that lacked a functional G1 domains and were not able to interact with hyaluronic
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acid and were assumed to be free in the ECM originally("non-HA-associated"). Aggrecan in both pools
was either left untreated or treated with the enzymes: Keratanase (K'ase) to remove the keratan sulfate
(KS) GAG chains or Chondroitinase ABC (C'ase) to remove the chondroitin sulfate (CS) GAG chains.
Aggrecan monomers were purified from all aggrecan digests under dissociative conditions. These
purified aggrecan molecules allow me to perform the AFM imaging experiments discussed in the next
session to study the individual molecular morphology.
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Figure 2-1: Procedure of aggrecan extraction and enzyme digesti
2.1.2 Aggrecan monolayer sample preparation monolayer
ion.
To visualize aggrecan proteoglycans, we using the tapping mode of AFM, the in vivo three dimensional
aggrecan monomers were deposited on the mica to obtain the two dimensional images. The
experiments have followed the steps described by L. Ng and coworkers [23](as illustrated in Figure 2-2):
(1) muscovite mica surfaces (SPI Supplies, West Chester, PA, #1804 V-5) were treated with 0.01% 3-
aminopropyltriethoxysilane (APTES; Sigma Aldrich Co., St. Louis, MO) v/v MilliQ water (18 M-cm
resistivity, Purelab Plus UV/UF, US Filter, Low-ell, MA), and this positively-charged APTES-mica surface
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facilitated electrostatic binding with the negatively-charged COO- and S03 groups on the GAG chains to
hold the aggrecan non-covalently on the surface to form a monolayer of aggrecan molecules; (2) fifty
microliters of aggrecan solution containing of 10 pg/ml GAG (measured from DMMB, Appendix B) were
deposited to the APTES treated mica surfaces for 30 min, and then rinsed with MilliQ water gently for 5 -
10 seconds; (3) after incubated in aggrecan monomer solutions and air-dried, the micas were imaged
with the tapping mode of AFM under ambient conditions.
AP-mica CS-GAG
mica APTES
0 0 Si " NH 3
i-OH OCH 2CH3
10 + CH3CH20-Si ' NH2!1--* >Si-- + NH I
0 OCH2CH3  +
91-0H 0- i NH3
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1+ + + + AP-mica + + +
Figure 2-2: AFM sample preparation. (Cited from reference [24]) Aggrecan monomers were deposited flatly onto
a positively charged mica surface and air-dried before AFM imaging.
2.1.3 AFM imaging and post-image processing
All AFM images were taken by Nanoscope Ilia Multimode AFM (Digital Instruments, Santa Barbara, CA)
and the tips used for all imaging are the rectangular Si cantilevers (AC240TS-2, Olympus, k = 2 N/m, tip
radius < 10 nm). The height and deflection data was recorded and optimized for high resolution of the
topology of aggrecan proteoglycans in the sample.
To date, I have directly visualized the individual aggrecan macromolecules from human
intervertebral disc in vitro using the methodology introduced here. To extract the relevant structural
parameters, height images of aggrecan proteoglycans were flattened to the first order for clearer
resolution, and then the trace length, Lt, and the end-to-end length, Ree, of the aggrecan core protein
were traced by customized Matlab scripts (illustrated in Figure 2-3). Furthermore, an extension value
was calculated by Equation 2-1. The contour length of GAG chains, Lt,GAG were also traced manually
using commercial software "SigmaScan Pro."
Equation 2-1: Ext = x 100
Lt
Figure 2-3: Extraction of aggrecan structural parameters: (a) the trace length, Lt, and the end-to-end length, R,
of the aggrecan core protein; (b) the contour length of GAG chains Lt,GAG-
2.2 Objectives
The goal of this project is three-folded:
1. Visualize the single molecular structure of aggrecan proteoglycans in human disc and quantify
their structural parameters;
2. Investigate the structural difference of aggrecan proteoglycans between the HA-associated and
non-HA-associated groups;
3. Study the structural change of aggrecan caused by enzymatic treatments to remove KS or CS
GAG chains.
2.3 Results - Conformational properties of healthy intervertebral disc aggrecan
2.3.1 Overview of the distribution of the human IVD aggrecan molecule sizes from the biochemistry
data and AFM measurement
Directly after the six specimens of aggrecan proteoglycans were treated and purified, biochemical
analysis by agarose gel electrophoresis has been performed on them to get an overview of the
composition of aggrecan molecules in the samples (these experiments were performed by Peter
Roughley) and the result is as shown in Figure 2-4. The fine difference in the aggrecan structural
compositions among these six specimens is unveiled by AFM imaging discussed in later sections.
From Figure 2-4, we have two main impressions: (1) Non-HA-associated aggrecan molecules
contain smaller fragments as a whole compared to the HA-associated aggrecan molecules. (2)The
untreated molecules are more heterogeneous in size compared to the K'ase treated or C'ase treated
ones in both the HA-associated and non-HA-associated pools. These findings are consistent with the
structural properties by AFM imaging summarized in Section 2.2.4, and the details of AFM imaging
results will be introduced as followed. Despite the apparent agreement of the data obtained by AFM
imaging technique and gel electrophoresis method, AFM imaging technique provides a finer distribution
and detailed analysis of individual molecular morphology.
HA-associated Non-FHA-associated
Figure 2-4: Biochemical analysis by agarose gel electrophoresis of six different specimens of aggrecan molecules
extracted from a 24 year old human intervertebral disc (provided by Peter Roughley, Shriner's Hospital,
Montreal).
From Table 2-1, we can see that human IVD aggrecan on average is much shorter (162.5 ± 10.3
nm, Mean ± SE) and more heterogeneous than those from the articular cartilage from a similar age
group. A previous graduate student in Grodzinsky's lab has imaged and analyzed using the same
protocols aggrecan molecules extracted 29 yr-old human knee articular cartilage [25], which study has
reported a contour length of the protein core Lt to be 216 ± 10 nm (Mean ± SE). That study also showed
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in human articular cartilage, the average core protein contour length L, of the full length untreated
aggrecan (with both the G1 and G3 domains visible) was measured as 474 ± 56 nm (19 monomers
measured). The difference between proteoglycans in articular cartilage and those in the disc has been
previously studied by electron microscopy [26], and our result is consistent with their conclusions. If the
core protein in both tissues were synthesized to have the exactly same amino acid sequence of the
protein core to start with [21], the difference of this distribution between the IVD aggrecan and the
articular cartilage aggrecan indicates that the aggrecan in the disc is comparatively more degraded and
that the disc has less capability for intrinsic repair and regeneration[27] due to the avascular nature of
disc tissues.
Table 2-1: Measured aggrecan structural parameters. (n is the sample number. "C'ase treated" stands for
aggrecan treated by Chondroitinase ABC, and "K'ase treated" for aggrecan treated by Keratanase 11)
Sample Sample Size L, /nm Ree /nm
Type (n) (Mean ±SE) (Mean ±SE)
HA- Untreated 319 162.5 ± 10.3 42.5 ± 0.8
associated K'ase treated 152 166.0 ± 10.0 38.2 ± 1.5C'ase treated 112 110.9 ± 7.6 18.8 ± 0.8
Non-HA- Untreated 242 131.4 ± 8.6 76.6 ± 1.1
associated K'ase treated 126 144.0 ± 8.6 16.4 ± 0.7
C'ase treated 130 76.3 ± 5.6 22.3 ± 0.7
The histogram of the trace length of aggrecan protein core, Lt, in the HA-associated and non-HA-
associated pools with three subgroups: (1) untreated aggrecan molecules; (2) Keratanase (K'ase) treated
aggrecan molecules and (3) Chondroitinase ABC (C'ase) treated aggrecan molecules, is summarized in
Figure 2-5. Further, the measurement of both the trace length, Lt, and the end-to-end distance, Ree,
from all six specimens are shown in Figure 2-6. The following sessions will focus on discussing the
difference between the HA-associated and the non-HA-associated groups (Section 2.3.2) and the effects
of enzyme digestion (Section 2.3.3).
2.3.2 HA-associated vs. Non-HA-associated
From this study, non-HA-associated aggrecan was found to be significantly shorter (p<0.01) than the HA-
associated molecules based on the measurement of both the trace length, Lt, and the end-to-end
distance, Ree. In addition, very few full-length aggrecan molecules (possessing both Gi and G3 domains)
were observed in the disc specimens, further suggesting that the young adult IVD aggrecan is more
extensively degraded compared to young adult articular cartilage aggrecan.
As shown in the insets of Figure 2-5 and other AFM images which are not reported here,
aggrecan in the HA-associated and non-HA-associated pools have a very similar appearance even before
or after K'ase and C'ase treatment. This suggests that many of the non-HA-associated aggrecan
molecules are of a similar structure to the HA-associated aggrecan, but lack the G1 domain.
(a) Untreated b) K'ase treated (c) C'ase treated
40i 30 40
30 2 30
S 20 20
510 F
t -10 6Onm 0 10
0-0
. 0 100 200 300 400 500 600 0 100 200 300 400 500 0 100 200 300 400
Trace Length of Core Protein L ) Trace Length of Core Protein L (nm) Trace Length of Core Protein L (nm)
(d)30- ep30 40-
20 20 30
*U 0
CCr C
10010 0 30 20
E 1 L 10
0- oo 0 1110 M0
0 100 200 300 400 500 600 0 100 200 300 400 500 0 100 200 300 400
Trace Length of Core Protein Lt (nm) Trace Length of Core Protein Lt (nm) Trace Length of Core Protein Lt (nm)
Figure 2-5: Histogram of the trace length of aggrecan protein core, L, in the HA-associated (a) - (c) and non-HA-
associated (d) - (f) pools: (a) and (d) for untreated aggrecan molecules; (b) and (e) for Keratanase treated
aggrecan; (d) and (f) for Chondroitinase ABC treated aggrecan. Insets show the AFM height images of individual
aggrecan molecules from each aliquot.
The wide distribution of the molecule size of human IVD aggrecan suggests a high heterogeneity
due to the accumulation of aggrecan degradation products in the human disc. The vast accumulation of
such degradation products that do not interact with HA does not occur in articular cartilage and arises
because of entrapment of fragments in the unique matrix organization of the disc.
Regarding the standard deviations of the lengths L, and Ree, the non-HA-associated group shows
a narrower variance. This may be biological understood as the process of aggrecan degradation is highly
and systematically regulated by aggrecanases which primarily target the interglobular domains between
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the GI and G2 domains. Once the aggrecan molecules are detached from the HA due to the
degradation, they are not subjective to the enzyme degradation anymore.
2.3.3 Effect of enzymatic treatments to remove specific GAG chains
AFM height images have shown that the core protein of the C'ase treated HA-associated molecules (Lt =
110.9 ± 7.6 nm, n = 112) was significantly shorter (p < 0.01) than the untreated molecules (Lt =162.5
10.3 nm, n = 319) (Figure 2-5(a) & (c)). On contrary with the C'ase treated aggrecan molecules, the
contour length Lt for K'ase treated HA-associated aggrecan (Lt =166.0 ±10.0 nm, n =152) was not
significantly different from untreated molecules. Similar trends were observed for the non-HA-
associated pool (Figure 2-5 (d) - (f)).
These data suggest that the core protein of aggrecan is extended by the presence of the CS GAG
chains, presumably due to repulsive electrostatic double layer and steric effects of intra- and/or
intermolecular interactions. The variations of Lt among three subsets (untreated, K'ase treated, and
C'ase treated) agree with the experimental work previously done on rat chondrosarcoma [28], and both
studies have suggested that the only factor of the phenomenological polydispersity in proteoglycans is
the variation of chondroitin sulfate chains. This may be due to the elastic stretching of the core protein
by the mutual repulsion of the negatively charged CS chains. Physiological, these electrostatic
interactions between the neighboring CS GAG chains have the major contribution to maintain the tissue
integrity by maintaining the osmotic pressure of the tissues and absorbing the mechanical shocks, while
the interactions between KS GAG chains are comparably much weaker. As such, the specific
contribution of KS GAG chains to the mechanical properties of the aggrecan molecules or the tissues as a
whole has not been investigated much in the literature, and the biological functions of the KS GAG
chains require further studies to be understood.
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Figure 2-6: Comparison of (a) means of trace length Lt, and (b) means of end-to-end distance Re,, of aggrecan
protein core measured by AFM imaging (error bars indicating the standard errors. Statistical test: 3-way ANO VA,
* = p < 0.01).
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2.3.4 Measurement of GAG chains of untreated aggrecan molecules
The single molecule imaging by AFM allows us to individually trace the contour lengths of GAG chains
without any distinguishment between the CS and KS GAGs. I have measured both the untreated and
K'ase treated aggrecan molecules in the 24 year old human intervertebral disc (method illustrated in
Figure 2-3(b)), and the results are summarized in Figure 2-7. Since the KS GAGs in C'ase treated
aggrecan molecules (Figure 2-8(b)) are both sparse and short, they are not able to be identified
individually and thus there is no report here for the GAG trace lengths of C'ase treated aggrecan.
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Figure 2-7: Histogram of the trace length, LtGAG ,of GAG chains attached to the aggrecan molecules extracted
from the 24 year-old human intervertebral disc: (a) HA-associated and untreated; (b) non-HA-associated and
untreated; (c) HA-associated and Keratanase treated; (d) non-HA-associated and Keratanase treated.
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Comparing subfigures (a) and (b) in Figure 2-7, non-HA-associated and untreated aggrecan
molecules have marginally longer GAG chains (LtGAG= 30.3 ± 0.4 nm), but not significantly different from
those from the HA-associated and untreated aggrecan molecules(LtGAG= 32.0 ± 0.8 nm). Statistical
analysis was performed using the student's t-test assuming unequal variances and the calculated p-value
is 0.07. The possible explanation is that HA-associated molecules consist of a higher portion of KS GAG
chains, and at the same time, AFM imaging is not capable of distinguishing the "brushes" as KS or CS
GAGs as their similar appearance. Since the KS-enriched region is located near the N-terminus of the
molecules (G1), it is more probably for the HA-associated aggrecan to retain that region with a
concentrated KS GAG attachment, and the KS GAG chains in aggrecan are known to be shorter than
aggrecan CS GAGs. However, the observed trend in the untreated aggrecan molecules is reversed in the
K'ase treated aggrecan, and this may be contributed to the fact that all KS chains which may be mistaken
as CS chains under AFM imagine have been removed by enzyme Keratanase.
2.3.5 Direct visualization of keratan sulfate chains
(a)
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Figure 2-8: (a) Some biochemistry experiments have already shown that a small portion of the total keratan
sulfates were distributed along the chondroitin sulfate enriched region located by the C-terminus of the
molecule; (b)AFM height images of C'ase treated and HA-associated aggrecan molecules.
We have observed KS chains in both the KS-enriched region and CS-enriched region, while a previous
study has only observed KS GAGs in the KS-enriched region of C'ase treated aggrecan extracted from 29-
yr old human articular cartilage [25]. This may suggest some different biosynthesis or post-translational
processing of the intervertebral disc aggrecan compared articular cartilage aggrecan. Due to the
limitation of AFM imaging resolution, we proposed another experiment introduced in Section 4.2 to
confirm our conclusion that KS GAGs are also located in CS-enriched region along aggrecan protein core.
2.4 Conclusions
To conclude, I have imaged the single molecular structure of aggrecan from a healthy human
intervertebral disc (24 year old), and studied the fine structural difference between the HA-associated
and non-HA-associated aggrecan molecules and also investigated the effects of enzyme treatment,
Keratanase and Chondroitinase respectively. Compared to the articular cartilage, the disc aggrecan
appears highly degraded, composed mainly of short fragments, and this result is consistent with other
biochemistry data reported so far [12,22]. The methodology applied in this study can be used in
aggrecan extracted from other age groups to have a better mechanistic understanding of the correlation
between aggrecan degradation and disc degeneration.
The non-HA-associated molecules are composed primarily of the degradation products and arise
because of entrapment in the unique matrix organization of the disc. The human intervertebral disc is
confined between the two neighboring vertebral end plates and circumferentially by the outer AF, and it
is believed that aggrecan is synthesized in the central NP region and slowly diffuse out to the outer AF
region with age. It is assumed that as long as the non-HA-associated aggrecan molecules remain in the
disc, they can still aid in resisting the mechanical loadings since the fixed charged density of the tissue is
primarily determined by the negatively charged GAG chains. The accumulation of the non-HA-
associated aggrecan molecules does not happen in the articular cartilage, because the non-HA-
associated aggrecan will diffuse into the synovial fluid and gets lost from the tissue soon after being
generated by degradation.
The trace length of aggrecan core protein is extended by GAG chains, specifically by CS GAGs,
due to the electrostatic interactions. There is also a possibility that the protein core without GAG
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substitution will form local knots on a length scale that is shorter than the current AFM imaging
resolution. After the removal of attached CS GAG chains (KS GAG chains are fairly short and distributed
sparsely), the aggrecan protein core is free from the steric and electrostatic interactions contributed
from the GAGs and is essentially just a chain of amino acids. To maximize the entropy, the protein cores
tends to go form a rigid-rod-like conformation to a random-coil-like one, and the change of
conformation may also be accelerated by the positive charges on the APTES-mica surfaces. In other
words, the trace lengths we measured by AFM may be shorter than the real contour length of aggrecan
protein cores.
The AFM imaging technique also allows me to individually trace the GAG chain contour lengths.
The difference between the non-HA-associated and HA-associated in terms of GAG chain length are not
conclusive. It can be understood by the fact that aggrecan degradation process is mainly the proteolysis
of the protein core while the attached GAG chains, either KS GAGs or CS GAGs were maintained intact
during the aggrecan biosynthesis, transportation and proteolysis processes. The electrostatic
interactions between the neighboring GAG chains are the major source of the tissue osmotic pressure
under compressive loads. The quantitative analysis of these interactions may be achieved by the
method of approach using molecular dynamic simulation discussed in Section 4.4.
Keratan sulfate GAG chains were observed both in the KS-enriched region and CS-enriched
region of disc aggrecan. Studies from Roughley et. al. 2006 [22] have suggested that KS is localized in
the KS domain of human intervertebral disc but no certain conclusion can be drawn from the
experimental methods they applied. Currently, it is still not clear whether KS substitute is confined in
the KS-enriched domain (near N-terminus) and CS substitute in CS-enriched region. This puzzle gives
rise to the experimental design proposed in Section 4.2 and hopefully the proposed experiment can
address the puzzle one day. Then, the next question to ask is whether the confined or distributed
substitution of different sulfated GAG types has any biological functionality or significance, and this may
be answered by the coarse-grained aggrecan model proposed in Section 4.3.
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Chapter 3
Molecular Dynamic Simulation of Glycosaminoglycans
This chapter will switch the gear from AFM experiments to the simulation part of this thesis. Molecular
dynamic simulation is the perfect tool to study the length-scale or time-scale of biomolecules that are
not measurable even by the most cutting-edge experimental techniques, such as the AFM imaging
techniques introduced in Chapter 2. In this study, an implicit solvation model of three types of
tetrasaccharides of both sulfated and unsulfated chondroitin, namely, chondroitin 4-sulfate (C4S),
chondroitin 6-sulfate (C6S) and chondroitin (CN) was explored to study the dynamic properties of the
single sugar rings, and these data can be built upon for future scale-up studies of aggrecan molecules
(Section 4.3 and 4.4).
3.1 Literature review and motivation
3.1.1 Background and introduction
As we have discussed in Chapter 2, glycosaminoglycans (GAGs) play a central role in maintaining the
molecular structure of aggrecan molecules and they are also the major source of the tissue's
biomechanical properties such as maintaining the osmotic pressure under compression, due to the high
negativity of the charges contributed from the sulfate and carboxyl groups in GAG chains.
As illustrated in Figure 3-1, chondroitin is an unbranched polysaccharide consisting of repeating
disaccharide unites of D-glucuronic acid (GIcUA) and N-acetyl-D-galactosamine (GaINAc), alternatively
connected with P (143) and P (1 - 4) glycosidic linkages. Chondroitin can be sulfated at either 4- or 6-
carbon of the GaINAc residue, denoted as C4S and C6S respectively. In aggrecan, the sulfation types of
substituted chondroitin sulfates vary with age and species. For example, in human articular cartilage,
aggrecan in the newborn is primarily composed of C4S while the portion of C6S substitution increases
with age. [29] The same trend was observed in the other species as well. [30]
In literature, extensive studies have been attempted both experimentally [31-33] and
theoretically to study the physical properties of the glycosaminoglycans or aggrecan molecules [34] and
their role in extracellular matrix in cartilagous tissues. Compared to the experimental studies, very little
simulation work has been done specifically on aggrecan molecules. In the following sessions, I will first
review the two main approaches in to simulate single GAG chains, the molecular approach and the
continuum approach, and then introduce the only model in literature on aggrecan molecules.
Motivated by the increasing interest in simulating aggrecan so far in literature, I will propose in Section
3.1.5 a Molecular Dynamics (MD) simulation approach to set up coarse-grained aggrecan model.
GaINAcOSO- c OH
CH cH2 OH 3 CH 2OH /CO
-lAc NHAc
OH OH
I GaINAc-4/6-sulfate
S (1->3) linkage -- ( )n
B (1->4) linkage
Figure 3-1: Disaccharide repeat units of CN, C4S and C6S, alternatively connected with 0 (1+3) and 0 (1+ 4)
glycosidic linkages.
3.1.2 Coarse-grained molecular model of glycosaminoglycans
Bathe and co-workers [35-37] have applied a coarse-grained model for the study of the equilibrium
conformation and titration behavior of chondroitin, chondroitin sulfate and hyaluronic acid. In this
model, the backbone of GAG chains is coarse-grained into the sequence of chemical and virtual bond
depicted in Figure 3-2. The coarse-graining applied in this model significantly increase the
computational efficiency, and this allowed a study of a GAG chain as long as hundreds of repeat units of
disaccharides. By varying chains of simulated GAG chains, this study extracted the important properties
of GAGs, such as characteristic ratio, persistence length, titration, effect of PH on conformation and also
predication of osmotic pressure.
This model has captured most of the molecular structure of GAG chains, and is essentially a
freely-jointed chain model. The Monte Carlo simulation results of this model were consistent with the
experimental data available and also provided a conceptual insight into the chain conformation and
behavioral responses to environment change of four different types of GAGs.
A
A / c
c c c
C6 0-
3.1.3~C Cotium odl
_C3  ''
B/
05 4_
The continuum modeling approach towards aggrecan dated back two decades ago. Bushman and
Grodzinsky [38] compared a macroscopic model based on Donnan equilibrium and a microstructural
unit cell model represented by Poisson-Boltzmann (PB) equation, and showed that the latter model is
more consistent with experimental data on the swelling pressure of articular cartilage. Dean and
coworkers[39] expended the previous PB continuum approach to different geometry representation of
the molecular structure (Figure 3-3), and this work was originally motivated to understand the
experimental High-Resolution Force Spectroscopy (HRFS) data from the nanomechanic study of
opposing layers GAG chains by Seog et. a.[40]. The rod model used by Dean and co-workers included
the aspects of polymer molecular geometry and non-uniform molecular charge distribution inside the
GAG brushes and gave the best agreement to the available HRFS data.
Since the fixed charged density attributed from the GAG chains is the main source of the
swelling pressure of the tissues, the continuum model predicts well the macroscopic behavior such as
the repelling forces between the two opposing GAG surfaces. Geometrically speaking, the charged rod
model employed by Dean and the co-workers has the most similarity to the molecular level structure of
GAGs and also considers the non-uniform charge distribution inside the brush. As such, it provides
consistent results with the HRFS data. However, since the set-up of this model was built from the
experimental methods used in HRFS, it failed to consider the random orientation of the GAG chains (it
assumed that all GAG chains are standing up straight) in vivo and is hard to be expanded further to
model the dynamic properties of GAGs in the ECM.
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Figure 3-3: Schematic of (a) constant surface charge model, (b) constant volume charge model, and (c) charged
rod model in plane parallel geometry. (d-f) Schematic of the models with tip approximated as a hemisphere that
were used when comparing to experimental High-Resolution Force Spectroscopy (HRFS) data [40]. (Cited from
reference [39])
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3.1.4 Molecular theory of tethered polymers to investigate two interacting aggrecan molecules
Very few publications were specially on modeling aggrecan molecules. Though there have been quite a
few studies on the bottle-brush copolymers [41-43], setting up a theoretical model of bottle-brush-like
molecules with tethered weak polyelectrolytes like aggrecan is a fairly complex problem and
computationally expensive. Nap and Szleifer [44] attempted to use a molecular density functional
theory to model the two interactional aggrecan proteoglycans. Their work was motivated by the fact
that aggrecan molecules were located next to each other by binding to the HA in cartilage with an
average spacing of 15 - 40 nm [45], and this model was set up to understand how the interaction
between two aggrecan molecules would be affected by the environment (PH and salt concentration)
and the distance in between the two molecules.
R
Figure 3-4: Schematics of the theoretical model of two adjacent aggrecan molecules employed. D is the distance
from the centers of the cylinders. The dots on the polymer chains represent dissociated groups. The radius is not
to scale. (Cited from Nap and Szleifer 2008 [44])
In this model as schemed in Figure 3-4, the protein core of aggrecan was modeled as a long
cylinder with a fixed radius R = 0.5 nm, and the two rigid cylinders are placed parallel to each other with
a certain distance D. The GAG chains were modeled as end-tethered weak polyelectrolytes. The
molecular model is accomplished by representing all relevant contribution in a thermodynamic free
energy equation and by sampling Monte Carlo algorithm.
The advantage of this model is that it explicitly takes into account the molecular details and the
charge distribution of every molecular type including ions and this framework can be expanded to
model other end-tethered polyelectrolytes. On the other hand, Nap and Szleifer's model is an
"aggrecan-like molecule" or "simple aggrecan" as they called it, and by simplifying the protein core as
the rigid and infinite long rod, the single molecular structure of aggrecan won't be captured in this
model.
3.1.5 Proposal of molecular dynamic simulation
No molecular-level based model of a complete aggrecan molecule has been reported in the literature.
The complexity of an aggrecan model involves: (1) both the protein core and the attached GAG chains
are flexible polymer chains, and the approximation of a rigid rod model won't accurately compute the
single molecular conformation of aggrecan; (2) the tethered GAG chains are negatively charged
polyelectrolytes, and this electrostatic term in free energy makes the computation fairly expensive; (3)
the interest in understanding the molecules' response under compression requires a time-dependent
dynamic simulation where a continuum model will fail to account for the transport of water molecules
and ions and a model explicitly including all the water and ion molecules requires high computational
loads.
Facing the above three challenges in modeling aggrecan, I propose here to simulate a coarse-
grained aggrecan molecule by molecular dynamic simulation. Molecular dynamics (MD) is a form of
computer simulation in which atoms and molecules are allowed to interact for a period of time by
approximations of known physics, giving a view of the motion of the particles. MD simulations have
been extensively applied in the theoretical studies of biological molecules to investigate their structures,
dynamics and thermodynamics. An all-atom simulation of aggrecan can be computational expensive
and unnecessary, and a careful coarse-graining [46] based on some initial all-atom simulation can
dramatically increase the computational efficiency without losing any relative molecular details.
A question one can ask for this modeling scheme is that how much aggrecan can be coarse-
grained in terms of length-scale. We can roughly estimate the length scale based on the work by Bathe
et. al. described in Section 3.1.2. The intrinsic persistent length of GAG chains were found to be 7 - 10
nm, and the stretch of one disaccharide unit is typically around 1 nm. The comparison of these two
numbers suggest that we can coarse grain a whole sugar ring as one entity and this will not have much
effects on simulating the chain conformation.
The end goal of modeling aggrecan by MD will be accomplished by three steps. First, an all-
atom simulation of tetrasaccharides (five repeating units of disaccharides) is performed, and the choice
of a tetrasaccharides is that the length of the simulated chain is on the order of its persistent length. I
didn't directly borrow the all-atom simulation results from Bathe et. al. (2005) since his coarse-graining
is based on an all-atom simulation of one disaccharides and the simulated chain is not long enough to be
further coarse-gained than reported. Second, the free energies of essential interactions are extracted as
the basis for future coarse-grained modeling of aggrecan proteoglycans. Third, an aggrecan model is set
up by coarse-graining every sugar ring into two "atoms", one representing the center of mass and one
representing the center of charge (more detailed in Section 4.3). This thesis has accomplished the first
step.
3.2 Objectives
In this chapter, I will report the MD simulation I have done so far on tetrasaccharides of chondroitin and
chondroitin sulfates and the specific goals of this work are as following:
1. To study the conformation of both the unsulfated chondroitin (CN) and chondroitin sulfates
(both C4S and C65) at the all-atom level;
2. To investigate the applicability of the implicit solvation model to negatively charged poly-
saccharides such as aggrecan proteoglycans;
3. To extract the free energies of essential interactions as the basis for future coarse-grained
modeling of aggrecan proteoglycans.
3.3 Methods
3.3.1 Model Set-up
Molecular dynamics simulations were performed on the tetrasaccharides of unsulfated condroitin (CN),
4-sulfated chondroitin (C4S) and 6-sulfated chondroitin (C6S) using AMBER force field (or GLYCAM06
[47] since our simulation system is comprised solely of carbohydrates). The original conformation was
adapted from the Protein Data Bank (ID: 2KQO). A tetrasaccharides chain of C4S contains 248 atoms,
257 bonds, 476 angles and 853 dihedrals.
Atom-based Van der Waals and electrostatic interactions were calculated with a cutoff of 12 A.
An additional 1/r term is included in the Coulombic formula, thus the Coulombic energy varies as 1r2 .
This is effectively a distance-dependent dielectric term which is a simple model for an implicit solvent
with additional screening.[48] A minimum distance of 10 A was kept between the chondroitin
molecules and the edge of simulation box.[49] Periodic boundary conditions were applied. The partial
charges for each atom was determined by Gaussian 03W (license owned by Chemical Engineering
Department @MIT) using HF6-31g(d) basis. The dielectric constant was set to be 80 as water in room
temperature.
Here, "Amber force field" refers to the functional form used by the family of AMBER force fields.
This form includes a number of parameters; each member of the family of AMBER force fields provides
values for these parameters and has its own name. The functional form of a general AMBER force field
is summarized in Equation 3-1 with the four terms calculating the bond, the angle, the dihedral and the
pair-wise interactions respectively. The subset for carbohydrates of AMBER force field is the also known
as GLYCAM force field [47] (the input parameters were taken from the webpage:
http://glycam.ccrc.uga.edu/ccrc/pages/parameters.html). AMBER was chosen specifically because it is
reported to be more appropriate for protein-carbohydrate systems.[50] Aggrecan, the molecule of our
research interest, is made up with a protein core and carbohydrates as the side chains, and in future one
can easily add the protein core segments to the current model to build up the aggrecan molecules
without changing the force fields applied.
Equation 3-1:
Etotal Kr(r - req) 2 + K(O - Oeq) 2 + [1+ cos(nc0 -
bonds angles dihedrals
+~~ [~j - + Ek
3.3.2 Simulation procedures
Initial coordinates of tetrasaccharides were minimized using the steepest descent algorithm followed by
Polak-Ribiere version of the conjugate gradient algorithm. After energy minimization, the temperature
was gradually warmed up over a period of 200 ps from 0 K to 300 K by applying a Langevin thermostat
to model an implicit solvent. Finally, the system would be equilibrated at 300 K in Langevin dynamics
after 500 ps. Coordinates of all atoms were written every 50 fs while an integration step was taken
every 1 fs. The dynamics trajectory of 1 ns post equilibration (20000 sample data points in total) was
used for data analysis.
3.3.3 Software and post-processing
All simulations were conducted using the open source codes LAMMPS [51], a molecular dynamic
simulator with parallel communication. Conformation information was extracted by customized
MATLAB scripts and/or Python scripts.
The visualization of molecules cited in this work was realized by Visual Molecular Dynamics
(VMD), a molecular modeling and visualization computer program. [52]
3.3.4 Computational clusters
The initial work was performed on the High Performance Computing (HPC) core invested by
Computational and systems biology (CSBi) at MIT with permission by Mark Bathe
(mark.bathe@mit.edu). The cluster is located on the first floor of building NE47 at MIT (500 Tech Sq,
Cambridge, MA, 02139) and has one head node, thirty-two compute nodes and four CPUs per node.
The cluster encountered a fetal crush in June 2010. Most simulation done on this cluster was explicit
solvation models [53], i.e. all water molecules were accounted explicitly.
Since June 2010, I have transferred my simulation work from HPC core to the computational
cluster located on the fourth floor of building NE47. This computational cluster has only fives compute
nodes with 2 processors each, and the computational capacity is incomparable to HPC core. Thus, I was
limited to perform the implicit solvation model only. I used one month to set up the MPI and Torque
modules on this cluster to enable the parallel computing [54] and job queuing system. I will spare the
cluster set-up procedures from this thesis since it is not directly related to my research goal, but feel
free to contact me if you want detailed protocols for your future reference.
3.4 Results
As described in the previous section, the dynamics trajectory of 1 ns post equilibration was recorded
and analyzed to capture the detailed conformation of GAG chains on the molecular level. The
parameters analyzed to study the ring structure include Cremer-Pople puckering parameters, glycosidic
torsions, hydrogen bond, and helix structure. These quantitative parameters allow us to compare the
structural difference between the unsulfated and two types of sulfated chondroitin. Cremer-Pople
puckering parameters are to define monosaccharide ring structure, glycosidic torsions how the
monosaccharides are connected, hydrogen bond the origin of certain glycosidic torsion and helix
structure the overall structure of an elongated sugar chain.
3.4.1 Cremer-Pople puckering parameters
Cremer-Pople puckering parameters [55] can be used to quantitatively describe a six-member puckered
sugar ring in spherical polar system by meridian angle cp, azimuthal angle 6, and radius Q. The radius Q
means the magnitude of puckering, measuring the deviation from the perfectly flat six-member ring (Q =
0). According to this system, there are 38 conformations represented: 2 chair (6= 0* or 180* at the
Poles), 6 boat (6 = 90* on the Equator), 6 skew-boat (6 = 900 on the Equator), 12 envelope (6 = 54.7* in
temperate zones), and 12 half-chair (6 = 50.80 in temperate zones). Regardless of the meridian angle rp,
the conformation at one Pole 6 = 0 is a stable chair one denoted as 4C1.
The simulation result of cremer-pople parameters are summarized in Table 3-1 and compared
with simulation results in literature (as in gray shading). Most rings in both unsulfated and sulfated
chondroitin models are in 4C1 chair conformation (defined as the azimuthal angle 6 is smaller than 600),
and chondroitin sulfates have more stable ring conformation than unsulfated chondroitin as shown in a
higher occupation in the chair conformation over the sample space. The stability of the ring
conformation is the basis of future coarse-graining, and if the ring puckers between different
conformations such as chair and boat, the center of mass of the whole ring would jump in space which
makes it hard to use a traditional translational mode to represent such movements.
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Figure 3-5: Schematics of Cremer-Pople representation. (Cited from http://www.ric.hi-ho.ne.jp/asfushi)
Table 3-1: Summary of Cremer-Pople parameters and the percentage of 4C1 chair conformation of three types of
chondroitin chains. aAqueous simulation of C4S using CHARMM force field (Almond et. al. 1998 (56]).
bExperimental data of CN using NMR as reported in Protein Data Bank (http://www.Pdb.org [57]).
C4S C6S CN C4Sa CN b
GaINAc4S Q 0.67 0.61 0.66 0.58 0.55
/ GalNAc6 15.75 9.83 14.12 8.78 1.89
/GaINAc 4C1  100% 100% 76.02% 100% 100%
GIcUA Q 0.58 0.58 0.59 0.59 0.55
0 11.07 12.59 11.85 8.80 6.86
4c, 99.99% 98.57% 92.32% 100% 100%
3.4.2 Glycosidic torsions
Glycosidic bonds are formed in between the neighboring monosacchrides in chondroitin, and the
dihedral angles to describe the glycosidic bonds are terms as glycosidic torsions. An analysis of the
glycosidic torsions in GAG chains can help us quantitatively define how the monossacchrides are linked.
The conformational exploration of disaccharide p (1--3) and @ (144) glycosidic linkages in all three
types of tetrasaccharides are summarized in Table 3-2. The contour plot of the @ (1-3) glycosidic
torsion energy is shown in Figure 3-6, and the contour plot of the p (1->4) glycosidic torsion energy
shares the similar feature. This energy contour plot is obtained by splitting the dihedral angle space into
small bins, and then calculating the probability of pairs of dihedral angles occurring at different grid
points and the energy in each bin based on the logarithm of the probability.
Table 3-2: Summary of glycosidic torsion angles of three types of chondroitin chains. a Aqueous simulation of
C4S using GLYCAM/TIP3 force field (Almond et. al. 2010 [58]). b Aqueous simulation of C6S from quantum
mechanics (Cilpa et. al. 2010 [591). c Experimental data of CN from NMR from Protein Data Bank.
C4S C6S CN C4Sa C6Sb CN c
p(H1-C1-01-C3) 55 18 51 21 18 76 40 t 17 48
(C-O1-0C3-H3) 18 ± 60 -22 ± 63 51 ± 76 -11 30 N/A -12
qp(H1-C1-01-C4) 42 15 45 t 13 -69 15 45
O(C1-01-C4-H4) -14 ± 101 -15 ± 65 -25 91 N/A N/A 0
cp(05-C1-01-C4) -66 & 18 -71 ± 21 -45 69 -79 ± 16 -109 -73
$(C1-01-C3-C4) 48 t 110 66 88 10 76 106 & 29 110 106
Sulfated chondroitin chains share similar torsion angles compared to unsulfated chondroitin.
This can be understood by the fact that hydrogen bonds were constantly forming intermittently
between the neighboring monosaccharides as we will see in the following section. The distribution of
the glycosidic torsions in the sulfated chondroitin is narrower compared to the unsulfated chondroitin,
and it may be because the hydrogen bonds formed in the sulfated chondroitin helped to stabilized the
chain structure. As such, the freedom of the torsion angle is more confined in the sulfated chondroitin
chains.
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Figure 3-6: Energy contour plots of J3 (14*3) glycosidic torsions.
3.4.3 Hydrogen bond
Hydrogen bonds were formed between neighboring monosacchrides alone the chain. To quantify the
presence of hydrogen bonds, the distances and the bond angles were calculated between all hydrogen
donors and acceptors, and a hydrogen bond is formed if the distance D-A < 3.5 A and the angle A-D-H <
300 (where D is the hydrogen donor, A is the acceptor and H is the hydrogen atom).
Interestingly, previously reported hydrogen bonds in unsulfated chondroitin [58] were observed
rarely in this implicit solvation model. The possible reason is that CN is less negatively charged (the total
charge of a tetrasaccharide chain of CN is negative five while it is negative ten for sulfated
tetra saccha rides), and this fact may render the implicit solvation model less applicable for unsulfated
condroitin.
For both 4- and 6-sulfated chondroitin chains, the hydrogen bonds were formed and broken
intermittently. As illustrated in Figure 3-7, there are basically three types of hydrogen bonds: N-H-C, 0-
H-C, and 0-H-0. Once the hydrogen bonds are formed, they stay bonded on the order of hundreds of
picoseconds and the hydrogen bonds persists 60 - 80% of the total simulation time. The long-lasting
hydrogen bonds formed in sulfated chondroitin, in addition to other chemical bonds, help to define the
glycosidic torsion and as such the helix structure.
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Figure 3-7: Appearance of hydrogen bonds in (a) C4S (b) C6S and (c) CN chains in the implicit solvation model. (d)
The hydrogen bond types "A" (N-H-0), "B" (0-H-0), and "C" (0-H-O) are visualized by VMD. (This example is
taken from C4S chain dynamics data post equilibration.)
3.4.4 Helix structure
The helix structure of chondroitin was mainly maintained by the intra-residual hydrogen bonds
across the glycosidic linkages. The helix structure of an elongated polymer chain, such as GAG chains
can be quantified by applying the parameters of the helical fold, n, representing the number of
disaccharides per turn and the helical rise, h, representing the axial rise per disaccharide.
In this study, the helical parameters of n and h were calculated using a general method
described by Sugeta & Miyazawa 1967 [60]. Previous studies have shown that the sulfated chondroitin
has a left-handed helix structure with n = 3 [56] or n = 4 [59]. Our implicit solvation model agrees with
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the previous studies by having an average of n = 2.62 for C4S, n = 3.63 for C6S and n = 3.75 for CN. The
helical rise, h, varies from 7 to 11 A over the dynamic simulation processes.
3.4 Conclusions
I have successfully set up a molecular dynamics model for the tetrasaccharides of the both the
unsulfated and sulfated chondroitin. The dynamic trajectory produced by the simulation can be used to
quantitatively analyze the single ring structure on the length scale of less than 1 nm.
In terms of all the single ring structural parameters I investigated in this chapter (Cremer-Pople
puckering parameters, glycosidic torsions, hydrogen bond, and helix structure), the simulation results
provided by the introduced implicit solvation models agrees with both the available experimental data
and explicit solvation models (Appendix E) to study highly negatively charged polysaccharides, namely 4-
and 6-sulfated chondroitin by preserving the ring conformation of monosaccharides and the
intermolecular hydrogen bonds. Similarity of both the monosaccharide ring conformation and the
overall tetrasaccharide conformation has been observed between 4 and 6- sulfated chondroitin. Implicit
solvation model can provide accurate results for highly charged system, and this result can provide some
guidance for other simulation works of choosing between the implicit and explicit solvation models
while the latter is highly computational expensive.
The current model can be served as the first step for the end goal of modeling aggrecan
molecules. I will discuss in the following chapter more details of the possible future work: (1) Section
4.3 will discuss how to build a coarse-grained aggrecan model based on the current all-atom model, and
the MD simulation has the advantage of investigating the dynamic responses of aggrecan upon external
forces (to simulate the compression in the ECM); (2) Section 4.4 will introduce the methodology of
exploring the inter-chain interactions between the neighboring GAG chains, and this may help us to
understand the GAG spacing designed by nature (~ 4 nm [24]).
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Chapter 4
Discussions and Future Directions
4.1 Study of disc aggrecan from different age groups
The study discussed in Chapter 2 has paved the approach to understand disc degeneration using the
state-of-art nano-imaging technology. This kind of multidisciplinary approach to science problems is a
general trend for a lot of research studies nowadays. The same experimental methods and statistical
analysis combing the biochemistry, nanomechanics and statistical analysis can be applied to human disc
aggrecan sample from other age group and disease groups. Our collaborator Peter Roughley was kind
enough to provide some of these samples (a 37-year old human disc sample and a 15-year old human
disc sample), and some interesting studies can be done on these samples using AFM imaging techniques
we introduced. A more feasible direction for someone who wants to study disc degeneration can start
with the relatively abundant porcine aggrecan.
4.2 Identification of keratan sulfate chains.
It was agreed among biologists that the keratan sulfate enriched region is located in the proximity of the
N-terminus of aggrecan, but there lacked a quantitative analysis of the distribution of the keratan
sulfates along the chondroitin sulfate enriched region located near the C-terminus of the molecule.
Some biochemistry experiments have already shown that a small portion of the total keratan sulfates
were distributed along the chondroitin sulfate enriched region located in the C-terminus of the molecule
[61], which other biologists hold skepticism over. Our AFM image capable of resolving the single
molecular structure of Chondroitinase ABC treated aggrecan molecules may aid in the understanding of
the binding and the function of keratan sulfates. The difficulty lies in distinguishing keratan sulfate and
degraded chondroitin sulfate based on the fact that both are of short lengths.
Our thought experiment, illustrated in Figure 4-1, is designed as an attempt to identify keratan
sulfates specifically for the purpose of finalizing the debate over their distribution along aggrecan core
protein. Firstly, we will digest the aggrecan proteoglycans (mainly "full-length", obtained from calf
cartilage) Chondroitinase ABC to remove all the CS GAGs. Then, we will incubate the Chondroitinase
ABC treated aggrecan molecules with KS antibodies, 5D4, provided by our collaborator Bruce Caterson
[62]. The KS antibodies will specifically bind to the keratan sulfates, and this enables us to localize their
distribution by visualizing little bulbs under AFM.
KS enriched region
G1 1
Figure 4-1: Thought experiment scheme for identifying keratan sulfates along core protein.
I have extracted aggrecan proteoglycans from 1-2 weeks old bovine calves (research 87,
Marlborough, MA) and treated these aggrecan molecules with Keratanase with an effort to prepare the
materials required for this thought experiments (Appendix A&C). A representative AFM image of the
digested calf aggrecan molecules is shown in Figure 4-2. We can see clearly the CS GAG chains have
been cleaved, leaving a flexible rod shape protein core, and the KS GAG chains are hard to be identified
since they are very short (5-15 kDa). Judged from the contour length of the calf aggrecan molecules, we
can tell there has been a low level of proteoglycan proteolytic cleavage as we expected. Further
identification and localization of KS GAG chains can be realized by the proposed thought experiments.
The anticipated difficulty will be (1) the fine tuning of relative portions of KS antibodies and the aggrecan
solutions because the excess KS antibodies can contaminate the image qualities by AFM, (2) the
separation between the aggrecan core proteins and Chondroitinase ABC due to their similar molecular
weights (the bright dots in Figure 4-2 can be the unpurified Chondroitinase ABC).
Despite my insufficient literature review of the related protocols, I would like to propose here
the tentative experimental protocol of this thought experiment, and I am still hoping one day some
graduate student (or maybe undergraduate student) would make this interesting project work (This
protocol was adapted from Roberts et. al. 1994 [63] and Sorrell et. al. 1988 [64]):
1. Make the buffer: 0.1 M TRIS-acetate (adjust to PH = 8.0).
2. Dilute the original KS antibody solution with 1: 3000 ratio (suggested).
3. Extract and purify aggrecan molecules. Treat the aggrecan with the Chondroitinase ABC. Adjust
the concentration of aggrecan solution to 1 mg/mL (can be quantified by DMMB analysis,
Appendix B).
4. Incubate the KS antibody together with aggrecan solution for 30 mins at room temperature.
5. Dilute the final solution to 10 - 100 pg/ml for AFM imaging.
Figure 4-2: The AFM height image of Keratanase treated aggrecan molecules extracted from 1 - 2 weeks old calf.
4.3 Coarse-grained aggrecan model
4.3.1 Coarse-graining scheme for GAG chains
As discussed earlier, previous work has shown that one can further coarse grain [46] the aggrecan side
chains based on the calculated persistence length of GAG chains (7~10 nm). Coarse-graining techniques
are a well-applied method to replace a few atoms in a macromolecule with a heavy virtual "atom," and
the simulation efficiency is greatly enhanced. Here, I will propose a coarse-graining scheme by which
each monosaccharide is replaced by two beads (shown in Figure 4-3): one bead representing the center
of mass (CM), and the other the center of charge (CQ). The bonds connecting the center of charge and
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the center of mass are rigid (this can be achieved by a high bonding coefficient in MD) to prevent high
thermal fluctuation of the massless bead CQ. The interactions coefficients between all the beads will be
calculated by the potential of mean force in the all-atom models.[65] The coefficients of interest include
the bonding coefficients, the angle coefficients and the dihedral coefficients.
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Figure 4-3: Coarse-graining scheme for GAG chains. Cm represents the center of mass of one monossachride, CQ
represents the center of charge of one monossachride and 0 is the glycosidic oxygen.
4.3.2 Coarse-graining scheme for aggrecan protein core
Regarding simulating the protein core of aggrecan proteoglycans, one simply applies a neutral freely-
jointed chain model or worm-like chain model [66]. Otherwise, one can also adopt coarse-graining on
aggrecan protein core in MD simulation.
According to Doege and coworkers [67], human aggrecan protein core has conservative
structure similar to the repetitive disaccharide units in GAG chains, which may allow us to use similar
coarse-graining scheme (to perform the MD simulation of a small repeating unit and then to coarse
grain it to simulate an elongated chain). In details, human cartilage aggrecan protein core has 2415
amino acids, and the GAG attachment sites are serine. The dominant regions with most dense GAG
attachment is chondroitin sulfate attachment domain 1 (CS-1), and this domain has repeating sequences
with conservative structure of 19-20 amino acids.
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One repeating unit in aggrecan protein core can be presented by 19 beads in MARTINI force
field [68], a common coarse-graining force field for protein. Using the nomenclature of MARTINI force
field, the sequence of 19 beads is Qa-C2-C1-Qa-P1-P1-P4-P1-P5-C2-Qa-Qa-C1-P1-P5-C1-Na-P1-P5 (P:
Polar, N: Non-polar, C: Apolar, Q: Charged) and the second to the last amino acid is serine, the binding
site for GAG chains.
4.4 Inter-chain interactions of neighboring GAGs
4.4.1 Motivation and background
It has been observed in the experiment [33] that certain orientation or alignment of neighboring GAG
chains can give rise to either repulsive or adhesive interactions as described in Figure 4-4. The adhesive
interaction was hypothesized to be derived from the hydrogen bonds aided by the Ca 2 ions. This
hypothesis can be further verified by the molecular dynamic simulation by adding specific ions.
There has been no simulation work done to study the inter-chain interactions between GAG
chains while the intra-chain interactions have been extensively explored previously as shown in Chapter
3. The model to study the inter-chain interactions can be simply built from the single chain model with
Steered Molecular Dynamics (SMD) [69].
The interaction between the two chains is the sum of the pair-wise interactions, and the pair-
wise interactions consist of Van der Waals interactions and electrostatic interactions (sometimes a tail
correction is added if a cut-off distance is applied to describe Van der Waals forces), i.e. Epo;,= Evdw +Ecout
(+ Etail ).
Steered Molecular Dynamics (SMD) is a simulation method by applying an external force to one
or more atoms with constant velocity or constant force. This method was based on the theory
Jarzynski's equality [70] which relates free energy differences to the work done through non-equilibrium
processes, i.e. (e )e .
b Unstrained state versus Strained state
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Figure 4-4: Schematics of (a) two opposing aggrecan macromolecules undergoing interpenetration and
entanglement in vivo; (b) network structure between aggrecan via self-adhesion due to Ca2.- mediated ion-
bridging and molecular entanglements between GAG chains, and energy dissipation of the Ca2*-ion-bridges upon
mechanically induced GAG molecular elongation (not drawn on scale); and (c) possible hydrogen bonding
dashed arrows), hydrophobic interaction (could occur between the methyl groups and carbon rings), and
Ca2 -mediated ion-bridging between CS-GAG chains in the presence of water molecules. Water bridges could
exist between the hydrogen bonding donors and acceptors. (Cited from Han et. aL. 2008 [33])
4.4.2 Model set up
Since SMD is an inherited feature in LAMMPS, one can simply adopt the single-chain modeling
introduced in Chapter 3 to study the inter-chain interactions. To study whether the sulfation type has
any effect, I propose here to align the two sulfated GAG chains (of the same sulfation type or of the
different sulfation type) either in the parallel direction or in the anti-parallel direction, as shown in
Figure 4-5.
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Figure 4-5: Schematics of the inter-chain model to study the interactions between neighboring GAG chains: (a)
the two GAG chains are aligned parallel to each other and (b) the two GAG chains are aligned anti-parallel to
each other.
The simulation procedures are described as following:
* Place two sulfated GAG chains with 30 A apart (with either parallel alignment or anti-parallel
alignment), and the left ends of both molecules (glycosidic oxygen 013) were fixed at the
desired points before applying forces (to prevent the chains from flowing around, which
scenario can make different simulation trials incomparable);
e Energy minimization;
e Gradually heat up from OK to 300K;
* Apply SMD coupling forces at both ends or at the centers of masses of two chains;
e Repeat the previous step till sufficient trials have been simulated for a meaningful average.[69]
4.4.3 Preliminary result
I did a test run of two parallel-aligned C4S chains (disaccharides) at T = 100 K and then pulled two chains
together at centers of mass starting from 3 nm. As we expected, the Van der Waals interactions
dominates at the atomic length scales (10 times higher than the Coulombic interactions), and we
observed an attraction well when the chain-to-chain distance is 2.5 A. When the two chains were far
away, the inter-chain interactions are negligible.
A deterministic result can be derived by applying multiple SMD simulations and take average
similar to the method described in Buehler 2006 [71].
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Figure 4-6: A test run of SMD simulation of two parallel-aligned C4S chains (disaccharide) at T = 100 K and pull
together at centers of mass from 30 A. (b), (c), (d) and (e) are the VMD visualization of the simulation chains at
points B ,C ,D and E in plot (a). (b) When the two chains were far apart, they don't feel each other and the
alignment is parallel. (c) The starting point that the two chains interact with each other with a tendency of chain
twisting. (d) An attractive force was established by the two chains due to Van der Waals interactions, and the
two chains align perpendicular to each other. (d) A high repulsion was observed, and the two planes of the
chains were perpendicular to each other.
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Appendix A
Protocol for Guanidine Extraction and Aggrecan Purification
This protocol was written by Paul Kopesky on February 29, 2008 as an adaption from protocols
developed by John Sandy and Anna Plaas. I have used this protocol to extract aggrecan proteoglycans
from 1-2 weeks old bovine calves (research 87, Marlborough, MA), which proteoglycans I have used for
control experiments to train my experimental skills. I would also highly recommend future students
who have an interest in working on human aggrecan molecules to use the well-characterized calf
aggrecan proteoglycans to train the experimental techniques in the starting stage. (There are more "full-
length" aggrecan molecules in calves.)
Materials:
* Guanidine HCI (4M)
* Sodium Acetate (100mM)
e Protease Complete Tablets (Roche)
Protocols:
1. Make desired volume of 4M Guanidine HCI in 100mM Sodium Acetate buffer and adjust pH to
~7.2. Rough guide: For tissue engineered plugs, make 1mL for every ~40mg of tissue wet weight
with sGAG content of ~120 ig (i.e. plug sGAG content is ~3pg/mg wet weight). I would double
the amount of extraction solution if using native tissue instead of engineered samples.
2. Add appropriate fraction of protease complete tablet per manufacturer's instructions. (Inhibits a
broad range of proteases).
3. Mechanically disrupt sample. May use a scalpel to dice (works for tissue engineered plugs). If
using native cartilage tissue, may want to pulverize and homogenize.
4. Add appropriate volume of combined solution samples as per step #1 above.
5. Mix on shaker at 4C for 48hrs (probably excessive, but will maximize PG extraction)
6. Spin for 0.5-1hr at ~16,000 x g in microcentrifuge at 4C.
7. Transfer clarified supernatant to new tube and discard pellet.
8. Add CsCI powder until solution density is 1.58g/mL. Check density by weighing a known volume
of solution.
9. Transfer sample to an appropriate tube for ultracentrifuge and balance ultracentrifuge rotor
exactly!!
10. Spin as long and as hard as you can. 72hrs at ~500,000 x g should produce a good density
gradient.
11. Immediately at the end of the spin, carefully pipette fractions of the sample. Splitting 1mL into
~10 x 100 pL fractions works well. Start by pipetteing off the very top and working down the
tube. Be aware that a hard pellet of CsCI may form at the bottom; the density gradient will likely
still be sufficient for PG purification.
12. Measure the density of the fractions as in step #8.
13. Combine fractions based on density. D1>1.54g/mL; 1.46g/mL<D2<1.54g/mL (Roughly &White.
JBC 255:217-224. 1980)
14. Dialyze with 500 volumes of IM NaCl for 4 hours (change the solution in the middle).
15. Dialyze with 500 volumes of MilliQ filitered distilled H20 overnight.
Important: Guanidine is a chaotropic agent and should be handled carefully.
Quantification:
For the final step of purification, half of the sample was purified by dialysis, and the other half was
purified by the spinning (I was just curious which purification procedure will give me the final gain of
purified products). Interestingly, even though the dialyzed sample appears much more viscous than the
spinned sample, they showed the similar concentration as shown in the Figure A-1 analyzed by
colorimetric method with the substrate DMMB analysis (Appendix B).
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Figure A-1: DMMB analysis of the prepared standard solution and diluted extracted aggrecan solution.
The GAG concentration in the spinned sample was found to be 1.19 mg/mL, and the GAG
concentration in the dialyzed sample was found to be 1.28 mg/mL.
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Appendix B
Protocol for dimethylmethylene blue (DMMB) analysis
Dimethylmethylene is blue-colored dye that can react with GAG chains, the change of dye's color can be
detected by the light absorbance. This absorbance is proportional to the substrate concentration (GAG
concentration in this case). This protocol was orally taught by Paul Kopesky and recorded by me.
Materials:
* Comercial CS GAG powder
e Dimethylmethylene blue (DMMB) solution
Protocols of standard curve:
1. Prepare the CS GAG solutions. 10 mg/mL (~1mL, calculated by weight dissolved in water).
2. Two serial 1:10 dilution and make 100 ug/mL stock GAG solution (100 uL standard + 900 uL
water).
3. Prepare the standard sample (200 uL in total for all standards)
Concentration (pg/mL) 0 12.5 25 50 75 100
Volume of stock (iL) 0 25 50 100 150 200
Volume of water (pL) 200 175 150 100 50 0
4. Dilution the aggrecan sample accordingly. Let the concentration of the diluted solution to be
roughly in the middle of the standards (~50 pg/mL).
5. Add 10 p of the standard solutions and 200 p DMMB into the wells on the plate. (Repeat for
several rows).
6. Read off 570 nm of absorbance of prepared solution.
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Appendix C
Protocol for Chondroitinase ABC Digestion of Aggrecan
This protocol was provided by Rachel Miller. With her help, I prepared some Chondroitinase ABC
treated aggrecan molecules extracted from 1 - 2 weeks calf (Figure 4-2).
Materials:
Chase Buffer (pH 7.6):
* 0.05 M Tris HCI (or Thris Base, corrected to pH 7.6)
* 0.05 M Na Acetate
* 0.01 M EDTA
[Note: To prepared 10 ml solution, use 60 mg Tris Base (MW 121.1), 41 mg Na acetate(MW 82.03), 37.2
mg EDTA (MW 372.2)]
Protocols:
1. Suspend 100 pg GAG lyophilized sample in 100 pl Chase Buffer:
2. Digest with protease-free Chondroitinase ABC (30 mU/ 100 pg GAG) (Warner) for 3 hours in a
water bath of 37 *C.
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Appendix D
Nanomechanics of human intervertebral disc
I have utilized the well-established protocols for micro-contact printing and high resolution force
spectroscopy [32] to quantify the nanoscale deformability and compressibility of functionalized
aggrecan. Aggrecan molecules are chemically end-grafted onto gold substrate and densely packed in a
hexagon regions. A micro-sized gold coated tip is used to compress the aggrecan pattern and data
analysis enables the calculation of an effective stress-strain curves. The measurements are obtained in a
fully hydrated fluid medium (NaCl solution), such that the ionic strength can be varied to mimic the
physiological environment. These experiments serve as testing the mechanical properties of the
intervertebral disc aggrecan in the physiological medium.
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Figure D-1: Nanomechanics results of disc aggrecan (24 year old human being, HA-associated, and untreated
aggrecan) under the ionic strength (controlled by NaCl concentration) of 0.001 mol/L.
The plan was to apply the above methodology to the untreated aggrecan in both the HA- and
the non-HA-associated group (Chapter 2). I did a few trials of nanomechanics experiments on untreated
and HA-associated sample. Unfortunately, I haven't got any satisfactory results. Previous
nanomechanics experiments [72] showed a height of aggrecan brushes by Pico-force is decreased to 200
- 300 nm (possibility due to a low friction force applied) even though a full-length aggrecan measured is
around 400 nm (from AFM imagining). Taking into account that the contour length measured by AFM
imagining of the human disc sample is less than 200 nm in average, measurement by AFM Pico-force
may be applicable for disc aggrecan.
Appendix E
Explicit solvation model
As I mentioned in Section 3.3.4 Computational clusters, I have done some explicit solvation model on
cluster HPC. Below I will just briefly explain what I have done, and the input files were generated by
customized Python scripts.
The simulation box is 7 nm X 7 nm X 7 nm, and was filled in the beginning with TIP3 water
molecules only (~10' molecules). The system first went through energy minimization, then gradually
warmed up to 300 K in NVT ensemble, and finally equilibrated at 300 K till the water density stabilized
around 1 g/cm 3 (1.021 ± 0.002 g/cm 3 in my simulation to be exact).
Solvated ions and the chondroitin chain (in energy minimized conformation) were added to the
equilibrated waterbox. To account for the physiological ionic strength (~0.15 mol/L) and the charge
neutrality, forty sodium ions (Na') and thirty chloride ions (Cl) were added. The simulations steps that
followed are be the same as those described in Chapter 3 for implicit solvation model. I only simulated
500 ps for each system at that time to test the robustness of my simulation systems, and the results are
consistent with the results as those in Chapter 3 in terms of Cremer-Pople parameters, glycosidic
torsions and hydrogen bonds. To save the space, I won't list them here again redundantly.
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Appendix F
LAMMPS input data files
The input date files for MD simulations in LAMMPS require the following information of the simulated
molecules:
1. The initial coordinates and velocities of atoms;
2. The bonds and their coefficients;
3. The angles and their coefficients;
4. The dihedrals and their coefficients;
5. The impropers and their coefficients.
The initial coordinates of atoms, the bonds, the angles, the dihedrals and the imporpers are solely
depend on the conformation of the molecule one wants to start with, the velocities can be scaled by the
temperature and all coefficients are determined by the force field applied. Writing the input files
manually is a tedious job and error-prone for large molecules, and there are tools developed for
LAMMPS users to generate the input files (http://lammps.sandia.gov/doc/Section tools.html) from
commercialized software AMBER, CHARMM, Materials Studio and etc (One should also check Protein
Data Bank to see whether there is experimental data available to be used as the initial conformation).
The basic idea is to use user-friendly software to create the conformation of simulated molecules and
then convert to the LAMMPS input files with appropriate syntax. This way one can have the ease of
creating the input files with a large number of atoms while enjoy the vase simulation capacity and
features provided by LAMMPS.
Chemical Engineering Department at MIT has licensed Accelrys Materils Studio software installed in
its Athena Cluster (66-080). I have tried the "msi2lmp" tool to convert msi files of a C4S chain created by
Materials Studio to the LAMMPS input file, but the following challenges were encountered:
1. msi21mp does not always output the cross-terms correctly
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2. It does not handle the failsafe parameters (with 'auto' suffix) in Force Fields (e.g.cff9l,cvff ...)
3. It doesn't support all force fields as LAMMPS does, the conversion is possible only if one chooses
to use the force fields of CFF91, CVFF and PCFF.
Therefore, in order to get exactly the same single point energy as that obtained from MS, in
LAMMPS we have to do two things:
1. To visually check the parameters already generated by msi2lmp.
2. To add additional terms to some pair interactions using '***_style hybrid' to include the fail safe
terms.
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